183 related articles for article (PubMed ID: 10357695)
1. The effect of thyroid hormone on skeletal integrity.
Greenspan SL; Greenspan FS
Ann Intern Med; 1999 May; 130(9):750-8. PubMed ID: 10357695
[TBL] [Abstract][Full Text] [Related]
2. Risk for fracture in women with low serum levels of thyroid-stimulating hormone.
Bauer DC; Ettinger B; Nevitt MC; Stone KL;
Ann Intern Med; 2001 Apr; 134(7):561-8. PubMed ID: 12803168
[TBL] [Abstract][Full Text] [Related]
3. Volumetric bone mineral density and bone geometry assessed by peripheral quantitative computed tomography in women with differentiated thyroid cancer under TSH suppression.
Tournis S; Antoniou JD; Liakou CG; Christodoulou J; Papakitsou E; Galanos A; Makris K; Marketos H; Nikopoulou S; Tzavara I; Triantafyllopoulos IK; Dontas I; Papaioannou N; Lyritis GP; Alevizaki M
Clin Endocrinol (Oxf); 2015 Feb; 82(2):197-204. PubMed ID: 25040693
[TBL] [Abstract][Full Text] [Related]
4. Effect of Thyrotropin Suppression Therapy on Bone in Thyroid Cancer Patients.
Papaleontiou M; Hawley ST; Haymart MR
Oncologist; 2016 Feb; 21(2):165-71. PubMed ID: 26659220
[TBL] [Abstract][Full Text] [Related]
5. Effect of TSH-suppressive doses of levothyroxine on bone mineral density in Thai women.
Ongphiphadhanakul B; Puavilai G; Rajatanavin R
J Med Assoc Thai; 1996 Sep; 79(9):563-7. PubMed ID: 8996984
[TBL] [Abstract][Full Text] [Related]
6. The effects of thyrotropin-suppressive therapy on bone metabolism in patients with well-differentiated thyroid carcinoma.
Heemstra KA; Hamdy NA; Romijn JA; Smit JW
Thyroid; 2006 Jun; 16(6):583-91. PubMed ID: 16839260
[TBL] [Abstract][Full Text] [Related]
7. The effect of thyroid stimulating hormone suppressive therapy on bone geometry in the hip area of patients with differentiated thyroid carcinoma.
Moon JH; Jung KY; Kim KM; Choi SH; Lim S; Park YJ; Park DJ; Jang HC
Bone; 2016 Feb; 83():104-110. PubMed ID: 26518742
[TBL] [Abstract][Full Text] [Related]
8. Effects on bone mass of long term treatment with thyroid hormones: a meta-analysis.
Uzzan B; Campos J; Cucherat M; Nony P; Boissel JP; Perret GY
J Clin Endocrinol Metab; 1996 Dec; 81(12):4278-89. PubMed ID: 8954028
[TBL] [Abstract][Full Text] [Related]
9. The relationship between serum TSH and bone mineral density in men and postmenopausal women: the Tromsø study.
Grimnes G; Emaus N; Joakimsen RM; Figenschau Y; Jorde R
Thyroid; 2008 Nov; 18(11):1147-55. PubMed ID: 18925834
[TBL] [Abstract][Full Text] [Related]
10. Bone mineral density in women receiving thyroxine suppressive therapy for differentiated thyroid carcinoma.
Chen CH; Chen JF; Yang BY; Liu RT; Tung SC; Chien WY; Lu YC; Kuo MC; Hsieh CJ; Wang PW
J Formos Med Assoc; 2004 Jun; 103(6):442-7. PubMed ID: 15278189
[TBL] [Abstract][Full Text] [Related]
11. The effect of levothyroxine therapy on bone mineral density: a systematic review of the literature.
Schneider R; Reiners C
Exp Clin Endocrinol Diabetes; 2003 Dec; 111(8):455-70. PubMed ID: 14714266
[TBL] [Abstract][Full Text] [Related]
12. [Bone mineral density in patients on long-term therapy with levothyroxine].
Korsić M; Cvijetić S; Dekanić-Ozegović D; Bolanća S; Kozić B
Lijec Vjesn; 1998 May; 120(5):103-5. PubMed ID: 9748785
[TBL] [Abstract][Full Text] [Related]
13. Bone changes in pre- and postmenopausal women with thyroid cancer on levothyroxine therapy: evolution of axial and appendicular bone mass.
Jódar E; Begoña López M; García L; Rigopoulou D; Martínez G; Hawkins F
Osteoporos Int; 1998; 8(4):311-6. PubMed ID: 10024900
[TBL] [Abstract][Full Text] [Related]
14. Effects on bone mineral density by treatment of benign nodular goiter with mildly suppressive doses of L-thyroxine in a cohort women study.
Appetecchia M
Horm Res; 2005; 64(6):293-8. PubMed ID: 16269872
[TBL] [Abstract][Full Text] [Related]
15. Is skeletal responsiveness to thyroid hormone altered in primary osteoporosis or following estrogen replacement therapy?
Langdahl BL; Loft AG; Møller N; Weeke J; Eriksen EF; Mosekilde L; Charles P
J Bone Miner Res; 1997 Jan; 12(1):78-88. PubMed ID: 9240729
[TBL] [Abstract][Full Text] [Related]
16. Lack of deleterious effect on bone mineral density of long-term thyroxine suppressive therapy for differentiated thyroid carcinoma.
Reverter JL; Holgado S; Alonso N; Salinas I; Granada ML; Sanmartí A
Endocr Relat Cancer; 2005 Dec; 12(4):973-81. PubMed ID: 16322336
[TBL] [Abstract][Full Text] [Related]
17. Thyroid hormone therapy in differentiated thyroid cancer.
Grani G; Ramundo V; Verrienti A; Sponziello M; Durante C
Endocrine; 2019 Oct; 66(1):43-50. PubMed ID: 31617165
[TBL] [Abstract][Full Text] [Related]
18. Thyroid hormone excess rather than thyrotropin deficiency induces osteoporosis in hyperthyroidism.
Bassett JH; O'Shea PJ; Sriskantharajah S; Rabier B; Boyde A; Howell PG; Weiss RE; Roux JP; Malaval L; Clement-Lacroix P; Samarut J; Chassande O; Williams GR
Mol Endocrinol; 2007 May; 21(5):1095-107. PubMed ID: 17327419
[TBL] [Abstract][Full Text] [Related]
19. Is excessive weight gain after ablative treatment of hyperthyroidism due to inadequate thyroid hormone therapy?
Tigas S; Idiculla J; Beckett G; Toft A
Thyroid; 2000 Dec; 10(12):1107-11. PubMed ID: 11201857
[TBL] [Abstract][Full Text] [Related]
20. Impact on bone of thyroid hormone therapy.
Lauwers A; Alexandre C
Rev Rhum Engl Ed; 1997 Feb; 64(2):112-9. PubMed ID: 9085446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
